# Study of SHP620 (Maribavir) in Healthy Adults

> **NCT02775240** · PHASE1 · COMPLETED · sponsor: **Shire** · enrollment: 18 (actual)

## Conditions studied

- Cytomegalovirus (CMV)

## Interventions

- **DRUG:** Digoxin
- **DRUG:** Maribavir
- **DRUG:** Dextromethorphan

## Key facts

- **NCT ID:** NCT02775240
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-21
- **Primary completion:** 2016-09-12
- **Final completion:** 2016-09-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02775240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02775240, "Study of SHP620 (Maribavir) in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02775240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*